Drug Trial Radar · NCT00044291
Phase III Study of Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer
Last checked: Nov 20, 2026Latest source record: Jul 31, 2015 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
865
Actual
Start
Jun 2002
Primary completion
Jan 2006
Study completion Jan 2006
Sponsor
- Lead sponsor
- Intarcia TherapeuticsIndustry
- Sponsor type
- Industry
- First posted
- Aug 27, 2002
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- Female only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine whether the first line combination hormonal therapy of an experimental drug, atamestane, plus an FDA-approved drug, toremifene (Fareston®), is more effective than another approved drug, letrozole (Femara®), in delaying the growth of breast cancer in postmenopausal patients with locally advanced or metastatic breast cancer, and whether the side effects of the combination are different from the side effects of letrozole.
Conditions
- Breast Neoplasms
- Neoplasms, Hormone-dependent
Interventions
atamestaneDrug
toremifeneDrug
letrozoleDrug
aromatase inhibitionDrug
hormone therapyProcedure
endocrine therapyProcedure
antiestrogen therapyProcedure
Primary outcomes
What the sponsor says the trial is designed to measure.
- Time to tumor progressionTime frame: time from randomization to first occurrence of tumor progression, assessed at week 12 and every subsequent 12 weeks for patients continuing in the study for up to approximately 36 months
Locations
63 sites in 4 countries. Site status is shown where the registry gives one.
Midwest Internal Medicine, PLLC
Lake Havasu City, Arizona
Arizona Clinical Research Center
Tucson, Arizona
California Cancer Care, Inc.
Greenbrae, California
Sharp Memorial Hospital
San Diego, California
Innovative Medical Research of South Florida Inc.
Miami Shores, Florida
Georgia Cancer Specialists
Tucker, Georgia
Maryland Hematology/Oncology Associates
Baltimore, Maryland
Oncology Care Associates, PLLC
Saint Joseph, Michigan
Kansas City Oncology and Hematology Group
Kansas City, Missouri
Great Falls Clinic-Oncology West
Great Falls, Montana
Slocum-Dickson Medical Group
New Hartford, New York
Hematology Oncology Consultants, Inc.
Columbus, Ohio
Oncology Consultants
Houston, Texas
First Dynamic Healthcare Services, Inc.
Killeen, Texas
Cache Valley Cancer Treatment & Research Clinic
Logan, Utah
Virginia Oncology Associates
Norfolk, Virginia
Western Washington Oncology Inc., P.S.
Olympia, Washington
Ottawa Regional Cancer Centre
Ottawa, Ontario, Canada
Northwestern Ontario Regional Cancer Centre
Thunder Bay, Ontario, Canada
Princess Margaret Hospital
Toronto, Ontario, Canada
McGill University, Department of Oncology
Montreal, Quebec, Canada
Arkhangelsk Regional Oncology Center, Department of Chemotherapy
Arkhangelsk, Russia
Tatarstan Republican Clinical Oncology Center
Kazan', Russia
Krasnodar Regional Clinical Oncology Center, Chemotherapy Department
Krasnodar, Russia
Lipetsk Regional Oncology Center, Department of General Oncology
Lipetsk, Russia
Blokhin Cancer Research Center, Department of Chemotherapy and Combined Treatment of Tumors
Moscow, Russia
Blokhin Cancer Research Center, Department of Chemotherapy
Moscow, Russia
Blokhin Cancer Research Center, Department of Clinical Pharmacology and Chemotherapy
Moscow, Russia
Blokhin Cancer Research Center, Department of New Antitumor Drug Research
Moscow, Russia
Hertzen Research Institute of Oncology, Department of Chemotherapy
Moscow, Russia
Central Clinical Hospital of the Ministry of Transport n.a. Semashko, Department of Chemotherapy
Moscow, Russia
Moscow City Hospital #40, Department of Chemotherapy
Moscow, Russia
Moscow City Oncology Hospital #62
Moscow, Russia
Murmansk Regional Oncology Center
Murmansk, Russia
Municipal Clinical Hospital #1, Department of Breast Tumors, Oncology Department
Novosibirsk, Russia
Medical Radiological Research Center
Obninsk, Russia
Ryazan Regional Clinical Oncology Center
Ryazan, Russia
Leningrad Regional Oncology Center
Saint Petersburg, Russia
St. Petersburg City Oncology Center
Saint Petersburg, Russia
Laboratory of Thoracic Oncology, St. Petersburg Pavlov State Medical University, Research Institute of Pulmonology
Saint Petersburg, Russia
Showing 40 of 63 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.